Damakant Jayshi After months of delay, drugmaker Novavax submitted its request to the U.S. Food and Drug Administration to grant its COVID-19 vaccine an emergency use authorization (EUA), the biotechnical company said in a statement on Monday. “The request for EUA is based on the totality of pre-clinical, clinical and manufacturing-related (CMC) data provided to […]
